Back to Citadel Advisors LLC Citadel Advisors LLC

OBIO

13 quarters

Position history for Citadel Advisors LLCCitadel Advisors LLC's holdings in Orchestra BioMed Holdings, Inc.

Yes. Citadel Advisors holds 56,191 shares of OBIO (Orchestra BioMed Holdings), worth $242,464, as of its Q2 2026 13F filing. It reduced the position by 22,994 shares (-29.0%) from Q1 2026. Citadel Advisors has held OBIO since Q3 2024, across 8 quarterly 13F filings.

Current Value

$242,464

Current Shares

56,191

Total Value Change

-$3.1M

Total Shares Change

-114,230

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
56,191
-29.0%
$242,4640.0%$4.32
0
2026-Q1
Increased
79,185
+162.4%
$336,5360.0%$4.36
38
2025-Q4
Decreased
30,175
-44.1%
$125,2260.0%$4.14
0
2025-Q3
Increased
54,002
+9.2%
$133,9250.0%$2.46
17
2025-Q2
Increased
49,441
+141.4%
$132,5020.0%$2.78
24
2025-Q1
Increased
20,480
+66.8%
$87,6540.0%$4.40
22
2024-Q4
Decreased
12,279
-39.0%
$49,1160.0%$4.25
0
2024-Q3
New
20,115
-
$103,3910.0%$5.02
33
2024-Q1
Exited
0
-100.0%
$00.0%$5.27
0
2023-Q4
Decreased
10,112
-94.1%
$92,3230.0%$9.13
0
2023-Q3
Unchanged
170,421
0.0%
$1.5M0.0%$8.72
0
2023-Q2
Unchanged
170,421
0.0%
$1.2M0.0%$7.57
0
2023-Q1
New
170,421
-
$3.3M0.0%$15.48
37

Other major holders of OBIO: RTW Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used